Literature DB >> 28352733

Study on correlation between bone marrow edema, stage of necrosis and area ratio of necrosis with the hip pain grading in nontraumatic osteonecrosis of the femoral head.

Wang Jianchuan1, Yang Lei1, Wang Benjie1, Zhao Dewei1.   

Abstract

The objective of this study was to explore the correlation between bone marrow edema, stage of necrosis, and area ratio of necrosis with the hip pain grading in non-traumatic osteonecrosis of the femoral head. Bone marrow edema grading at all levels and the hip pain grade differences were statistically significant (P < 0.001). Bone marrow edema grading increased by levels of 0, 1, and 2, whereas average pain rating increased as well to 40.73, 104.66 and 143.49. I ~ III period stage of necrosis and the hip pain grade difference was statistically significant (P < 0.001), with the average grade progress pain stage by the death of a rank gradually increased, I period, II period, III period was 57.00, 88.58 and 120.62, respectively. Area ratio of necrosis between 0 ~ 3 were positively correlated with pain, compared the two was statistically significant (P < 0.001), and with the degree of pathological changes is aggravating, increase the average rank of levels of pain. 0, 1, 2 and 3 are 36.88, 98.03, 123.87 and 151.93 respectively. We can choose the treatment method and evaluate treatment effect by considering a patients' degree of bone marrow edema, stage of necrosis and area ratio of necrosis.

Entities:  

Keywords:  Area ratio of necrosis; Bone marrow edema; Pain grading; Stage of necrosis

Year:  2015        PMID: 28352733      PMCID: PMC5368864          DOI: 10.1515/med-2015-0076

Source DB:  PubMed          Journal:  Open Med (Wars)


  6 in total

Review 1.  Managing pain: the fifth vital sign.

Authors:  M K Merboth; S Barnason
Journal:  Nurs Clin North Am       Date:  2000-06       Impact factor: 1.208

2.  Articular cartilage volume in the knee: semiautomated determination from three-dimensional reformations of MR images.

Authors:  M A Piplani; D G Disler; T R McCauley; T J Holmes; J P Cousins
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

3.  Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images.

Authors:  K H Koo; I O Ahn; R Kim; H R Song; S T Jeong; J B Na; Y S Kim; S H Cho
Journal:  Radiology       Date:  1999-12       Impact factor: 11.105

4.  Histological findings of bone marrow edema pattern on MRI in osteonecrosis of the femoral head.

Authors:  T Kubo; T Yamamoto; S Inoue; M Horii; K Ueshima; Y Iwamoto; Y Hirasawa
Journal:  J Orthop Sci       Date:  2000       Impact factor: 1.601

5.  Prognosis of early stage avascular necrosis of the femoral head.

Authors:  H Ito; T Matsuno; K Kaneda
Journal:  Clin Orthop Relat Res       Date:  1999-01       Impact factor: 4.176

6.  Magnetic resonance-detected subchondral bone marrow and cartilage defect characteristics associated with pain and X-ray-defined knee osteoarthritis.

Authors:  M F Sowers; C Hayes; D Jamadar; D Capul; L Lachance; M Jannausch; G Welch
Journal:  Osteoarthritis Cartilage       Date:  2003-06       Impact factor: 6.576

  6 in total
  3 in total

1.  Extracorporeal shock wave therapy for bone marrow edema syndrome in patients with osteonecrosis of the femoral head: a retrospective cohort study.

Authors:  Wenyi Zhao; Yuan Gao; Shouxiang Zhang; Zhang Liu; Lin He; Dahong Zhang; Wei Li; Qinggang Meng
Journal:  J Orthop Surg Res       Date:  2021-01-07       Impact factor: 2.359

2.  Is bone marrow oedema in patients with labral tear an indicator of hip pain?

Authors:  Tomohisa Koyama; Kensuke Fukushima; Kentaro Uchida; Yoshihisa Ohashi; Katsufumi Uchiyama; Naonobu Takahira; Masashi Takaso
Journal:  J Orthop Surg Res       Date:  2022-09-15       Impact factor: 2.677

Review 3.  Pericollapse Stage of Osteonecrosis of the Femoral Head: A Last Chance for Joint Preservation.

Authors:  Qing-Yu Zhang; Zi-Rong Li; Fu-Qiang Gao; Wei Sun
Journal:  Chin Med J (Engl)       Date:  2018-11-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.